141 related articles for article (PubMed ID: 1096051)
1. Treatment of allergic disorders with injections of allergen extracts.
May CD
Pediatr Clin North Am; 1975 Feb; 22(1):221-5. PubMed ID: 1096051
[No Abstract] [Full Text] [Related]
2. [Specific desensitization in hay fever with commercial allergen extracts].
Lowewe G
Z Arztl Fortbild (Jena); 1966 Nov; 60(21):1211-3. PubMed ID: 5990876
[No Abstract] [Full Text] [Related]
3. [Subcutaneous allergen-specific immunotherapy in patients with asthma and allergic rhinitis. 21st century].
Martín JP
Rev Alerg Mex; 2009; 56(2):27-9. PubMed ID: 19526950
[No Abstract] [Full Text] [Related]
4. Studies in hyposensitisation with Allpyral. Objective evaluation of the results.
Fagerberg E; Nilzén A; Wiholm S
Acta Allergol; 1972 Feb; 27(1):1-14. PubMed ID: 5067419
[No Abstract] [Full Text] [Related]
5. Multiallergen immunotherapy for allergic rhinitis and asthma.
Nelson HS
J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
[TBL] [Abstract][Full Text] [Related]
6. Treatment of allergic rhinitis with injections of allergenic extracts.
Med Lett Drugs Ther; 1973 Jun; 15(13):55-6. PubMed ID: 4576315
[No Abstract] [Full Text] [Related]
7. [Results of specific desensitization with aqueous allergen extracts].
Werner M; Gronemeyer W; Fuchs E
Dtsch Med Wochenschr; 1970 Apr; 95(16):877-82. PubMed ID: 5439541
[No Abstract] [Full Text] [Related]
8. ALLERGY TREATMENT. PERSONAL OBSERVATIONS WITH REPOSITORY ALLERGY THERAPY.
MEULBROEK HJ
J Kans Med Soc; 1964 Nov; 65():545-7. PubMed ID: 14216599
[No Abstract] [Full Text] [Related]
9. Anaphylaxis caused by allergen sublingual immunotherapy?
André C; Fadel R
Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
[No Abstract] [Full Text] [Related]
10. Repository treatment in house dust allergy.
Miller AC
Acta Allergol; 1971 Dec; 26(6):430-7. PubMed ID: 5172341
[No Abstract] [Full Text] [Related]
11. [Specific hyposensitization using pyridine extracts precipitated with aluminum. III. Intolerance to the extracts. Anatomo-pathological study of the receptor area].
Basomba A; Tamarit L; Peláez A; Villalmanzo IG
Allergol Immunopathol (Madr); 1974; 2(5):325-32. PubMed ID: 4218447
[No Abstract] [Full Text] [Related]
12. Evaluation of six years allergen immunotherapy in allergic rhinitis and allergic asthma.
Farid R; Ghasemi R; Baradaran-Rahimi M; Jabbari F; Ghaffari J; Rafatpanah H
Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):29-31. PubMed ID: 17242501
[TBL] [Abstract][Full Text] [Related]
13. [Desensitization in allergic diseases with semi-depot preparations].
Wüthrich B
Praxis; 1969 Oct; 58(42):1346-7. PubMed ID: 5396156
[No Abstract] [Full Text] [Related]
14. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous allergen immunotherapy in 3 patients with HIV.
Fodeman J; Jariwala S; Hudes G; Jerschow E; Rosenstreich D
Ann Allergy Asthma Immunol; 2010 Oct; 105(4):320-1. PubMed ID: 20934633
[No Abstract] [Full Text] [Related]
16. [Vaccination against allergies yields good symptom relief].
Hedlin G; Arvidsson M
Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1938-41. PubMed ID: 18681376
[No Abstract] [Full Text] [Related]
17. Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts.
Casanovas M; Martín R; Jiménez C; Caballero R; Fernández-Caldas E
Int Arch Allergy Immunol; 2006; 139(2):153-8. PubMed ID: 16374026
[TBL] [Abstract][Full Text] [Related]
18. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
Cochard MM; Eigenmann PA
J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352
[No Abstract] [Full Text] [Related]
19. One century of allergen-specific immunotherapy for respiratory allergy.
Incorvaia C; Frati F
Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
[TBL] [Abstract][Full Text] [Related]
20. Safety evaluation of rapid build-up schedules with IR-standardized allergen extracts for subcutaneous immunotherapy of allergic respiratory diseases.
Fernández-Távora L; Justicia JL; Moreno C; Tabar AI; Vidal C
Expert Opin Drug Saf; 2011 Nov; 10(6):947-55. PubMed ID: 21770817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
